tafamidis (Vyndaqel) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$1403.5180 - $3508.7950

VA FSS

$1846.7340 - $4616.8350

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tafamidis 61 mg (CAPSULE) $1403.5180 VA Big4
  • Vyndamax (10)
  • Pfizer, Inc.
    tafamidis 61 mg (CAPSULE) $1846.7340 VA FSS
  • Vyndamax (10)
  • Pfizer, Inc.
    tafamidis meglumine 20 mg (CAPSULE) $3508.7950 VA Big4
  • Vyndaqel (4)
  • Pfizer, Inc.
    tafamidis meglumine 20 mg (CAPSULE) $4616.8350 VA FSS
  • Vyndaqel (4)
  • Pfizer, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue